Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEHARRY MEDICAL COLLEGE via KING & SPALDING LLP
2026 · third_quarter · Q3
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Source: Senate LDA
| ASSOCIATION OF CLAIMS PROFESSIONALS (FORMERLY AAICP) |
| 41 |
| 2013–2023 |
| Amarin Pharma, Inc. | 36 | 2013–2024 |
| KANEKA PHARMA AMERICA, LLC | 35 | 2018–2025 |
| POINTCLICKCARE TECHNOLOGIES, INC. | 24 | 2021–2026 |
| SEDGWICK, INC. | 22 | 2013–2018 |
| KIDNEY TRANSPLANT COLLABORATIVE | 21 | 2021–2026 |
| ACADIA HEALTHCARE | 18 | 2022–2026 |
| OMEROS CORPORATION | 16 | 2014–2018 |
| ATARA BIOTHERAPEUTICS, INC. | 15 | 2021–2024 |
| THE BRINK'S COMPANY | 15 | 2013–2017 |
| GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS | 14 | 2020–2023 |
| TRANSMEDICS, INC. | 13 | 2021–2024 |
| AUDENTES THERAPEUTICS | 12 | 2018–2021 |
| BAUSCH HEALTH COMPANIES INC F/K/A VALEANT PHARMACEUTICALS INTERNATIONAL INC | 12 | 2017–2020 |
| BIOSCRIP, INC. | 12 | 2016–2019 |
| MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) | 12 | 2023–2026 |
| U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORM | 12 | 2015–2018 |
| BONE GROWTH STIMULATOR COALITION (INFORMAL COALITION) | 11 | 2018–2021 |
| SHIRE PHARMACEUTICALS | 11 | 2015–2017 |
| AMERICAN PSYCHIATRIC ASSOCIATION | 9 | 2015–2016 |
| EXAMWORKS | 9 | 2024–2026 |
| GREATER BALTIMORE COMMITTEE | 8 | 2025–2026 |
| MCS ADVANTAGE, INC. | 8 | 2017–2019 |
| MOLECULIGHT CORPORATION | 8 | 2025–2026 |
| VOICES OF ALZHEIMER'S, INC. | 8 | 2025–2026 |
| AMERICAN REGENT, INC. | 7 | 2020–2021 |
| ALERE, INC. | 6 | 2016–2017 |
| AMERICAN MEDICAL TECHNOLOGIES | 6 | 2020–2021 |
| HEARTFLOW | 6 | 2016–2017 |
| ACERA SURGICAL INC. | 5 | 2021–2022 |
| EGENESIS INC. | 5 | 2025–2026 |
| CIVATECH ONCOLOGY, INC. | 4 | 2015–2016 |
| MYTOMORROWS | 4 | 2017 |
| STOP THE WAIT COALITION | 4 | 2021 |
| AMERICAN COLLEGE OF MEDICAL GENETICS | 3 | 2015 |
| COALITION OF INDEPENDENT DISPUTE RESOLUTION ENTITIES, INC. (CIDRE) | 3 | 2026 |
| CONCEIVEX, INC. | 3 | 2016 |
| MARINE POLYMER TECHNOLOGIES, INC. | 3 | 2015 |
| SECURE HEALTHCARE QUALITY ALLIANCE, INC. | 3 | 2026 |
| TAURX PHARMACEUTICALS LTD | 3 | 2023 |
| UNITED CDPAP, INC. | 3 | 2024–2025 |
| ADVOCATE HEALTH ADVISORS | 2 | 2024 |
| HINGE HEALTH | 2 | 2022 |
| MEHARRY MEDICAL COLLEGE | 2 | 2026 |
| MR. SETH RABINOWITZ | 2 | 2019 |
| PUBLIC SECTOR ALLIANCE (INFORMAL COALITION) | 2 | 2014 |
| SYNCHRON, INC. | 2 | 2026 |
| FIRST KEY HOMES | 1 | 2026 |
| HENRY SCHEIN INC | 1 | 2014 |
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.), S. 3816 (119th Cong.).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Continuing Appropriations and Extensions Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations and Extensions Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations and Extensions Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations and Extensions Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations and Extensions Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
BRIDGE for Young-Onset Alzheimer’s Disease Act of 2025
Client: VOICES OF ALZHEIMER'S, INC. · Firm: KING & SPALDING LLP
Advocacy related to legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
BRIDGE for Young-Onset Alzheimer’s Disease Act of 2025
Client: VOICES OF ALZHEIMER'S, INC. · Firm: KING & SPALDING LLP
Advocacy related to legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
BRIDGE for Young-Onset Alzheimer’s Disease Act of 2025
Client: VOICES OF ALZHEIMER'S, INC. · Firm: KING & SPALDING LLP
Advocacy related to Legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Web of Biological Data Act of 2026
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Web of Biological Data Act of 2026
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Web of Biological Data Act of 2026
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Web of Biological Data Act of 2026
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Web of Biological Data Act of 2026
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Continuing Appropriations Act, 2027
Client: MEHARRY MEDICAL COLLEGE · Firm: KING & SPALDING LLP
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.), S. 3816 (119th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Dialysis-Related Amyloidosis Treatment Act of 2025
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Dialysis-Related Amyloidosis Treatment Act of 2025
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
To designate the facility of the United States Postal Service located at 324 Washington Avenue, Suite 1 in Grand Haven, Michigan, as the "Ell Thomas Simantz Post Office Building".
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).
To designate the facility of the United States Postal Service located at 324 Washington Avenue, Suite 1 in Grand Haven, Michigan, as the "Ell Thomas Simantz Post Office Building".
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Dialysis-Related Amyloidosis Treatment Act of 2024
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment; H.R. 8999.
Dialysis-Related Amyloidosis Treatment Act of 2024
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment; H.R. 8999.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation.
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Positioning the Election Assistance Commission for the Future Act of 2023
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Provide assistance on federal advocacy issues. FY 2027 Continuing Appropriations Act (H.R. 9770), FY 2027 Continuing Appropriations and Extensions Act (H.R. 6500; P.L. 119-103), HBCU IGNITE Excellence Act (H.R. 8791/S. 4528), Web of Biological Data Act (H.R. 9307).
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy related to legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2026 · third_quarter · Q3
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SECURE HEALTHCARE QUALITY ALLIANCE, INC. via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy related to the provision of healthcare in state and municipal jails and prisons.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
PHOTOCURE, INC. via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2026 · third_quarter · Q3
Lobbying on Medicare coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocate on Wound Care LCDs and payment rates; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.), S. 3816 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
EXAMWORKS via KING & SPALDING LLP
2026 · third_quarter · Q3
IDRE Program Advocacy.
Filing targets: HOUSE OF REPRESENTATIVES
EGENESIS INC. via KING & SPALDING LLP
2026 · third_quarter · Q3
Educate lawmakers on xenotransplantation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
COALITION OF INDEPENDENT DISPUTE RESOLUTION ENTITIES, INC. (CIDRE) via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocacy around No Surprises Act independent dispute resolution program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2026 · third_quarter · Q3
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy related to legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SYNCHRON, INC. via KING & SPALDING LLP
2026 · second_quarter · Q2
Approval and coverage of Brain Computer Interface products.
Filing targets: Executive Office of the President (EOP), White House Office
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2026 · second_quarter · Q2
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SECURE HEALTHCARE QUALITY ALLIANCE, INC. via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy related to the provision of healthcare in state and municipal jails and prisons.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
PHOTOCURE, INC. via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2026 · second_quarter · Q2
Lobbying on Medicare coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocate on Wound Care LCDs and payment rates; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy on Kidney Transplant Issues; LOVE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
EGENESIS INC. via KING & SPALDING LLP
2026 · second_quarter · Q2
Educate lawmakers on xenotransplantation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
EXAMWORKS via KING & SPALDING LLP
2026 · second_quarter · Q2
IDRE Program Advocacy.
Filing targets: HOUSE OF REPRESENTATIVES
COALITION OF INDEPENDENT DISPUTE RESOLUTION ENTITIES, INC. (CIDRE) via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocacy around No Surprises Act independent dispute resolution program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2026 · second_quarter · Q2
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act; licensure of treatment centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MEHARRY MEDICAL COLLEGE via KING & SPALDING LLP
2026 · third_quarter · RR
Provide assistance on federal advocacy issues
Provide assistance on federal advocacy issues
Provide assistance on federal advocacy issues
SYNCHRON, INC. via KING & SPALDING LLP
2026 · second_quarter · RR
Advocacy regarding approval and coverage of Brain Computer Interface Products.
Advocacy regarding approval and coverage of Brain Computer Interface Products.
SECURE HEALTHCARE QUALITY ALLIANCE, INC. via KING & SPALDING LLP
2026 · second_quarter · RR
Advocacy related to the provision of healthcare in state and municipal jails and prisons
COALITION OF INDEPENDENT DISPUTE RESOLUTION ENTITIES, INC. (CIDRE) via KING & SPALDING LLP
2026 · second_quarter · RR
Advocacy around No Surprises Act independent dispute resolution program
PHOTOCURE, INC. via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy related to Bladder cancer treatment and blue light cystoscopy, H.R. 8032.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy related to Legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2026 · first_quarter · Q1
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2026 · first_quarter · Q1
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate on Wound Care LCDs and payment rates; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy on Kidney Transplant Issues; LOVE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
EXAMWORKS via KING & SPALDING LLP
2026 · first_quarter · Q1
IDRE Program Advocacy.
Filing targets: HOUSE OF REPRESENTATIVES
EGENESIS INC. via KING & SPALDING LLP
2026 · first_quarter · Q1
Educate lawmakers on xenotransplantation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FIRST KEY HOMES via KING & SPALDING LLP
2026 · first_quarter · RR
Advocacy related to Institutional Investors
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · second_quarter · 2A
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy related to Legislation to eliminate SSDI waiting period for individuals with young onset Alzheimers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate on Wound Care LCDs and payment rates; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy on Kidney Transplant Issues; LOVE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2025 · fourth_quarter · 4T
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Filing targets: HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
EXAMWORKS via KING & SPALDING LLP
2025 · fourth_quarter · Q4
IDRE Program Advocacy.
Filing targets: HOUSE OF REPRESENTATIVES
EGENESIS INC. via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Educate lawmakers on xenotransplantation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA)
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Legislation to eliminate SSDI waiting period for individuals with young onset Alzheimers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · third_quarter · Q3
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocacy on Tricare pharmacy Issues; MEPA Legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · third_quarter · 3A
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · third_quarter · Q3
Lobbying on Medicare coverage issues
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate on Wound Care LCDs and payment rates; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy on Kidney Transplant Issues; LOVE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
EXAMWORKS via KING & SPALDING LLP
2025 · third_quarter · Q3
IDRE Program Advocacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
EGENESIS INC. via KING & SPALDING LLP
2025 · third_quarter · RR
Educate lawmakers on xenotransplantation.
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2025 · second_quarter · Q2
Legislation to eliminate SSDI waiting period for individuals with young onset Alzheimers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · second_quarter · Q2
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocacy on Tricare pharmacy Issues; MEPA Legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · second_quarter · Q2
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate on Wound Care LCDs; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy on Kidney Transplant Issues; Organ Donor Clarification Act. LOVE Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Small Business Administration (SBA)
EXAMWORKS via KING & SPALDING LLP
2025 · second_quarter · Q2
IDRE Program Advocacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · second_quarter · RR
Medicare Coverage Issues.
MARC COALITION via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
Provide assistance on federal advocacy issues
Provide assistance on federal advocacy issues